Gram-Negative Bacterial Resistance.

Antimicrobial resistance in gram-negative bacteria is driven by multiple factors and mobile genetic elements, with key mechanisms including β-lactamase production and reduced drug entry.

• Why it matters: The worldwide spread of resistance and limited access to effective antibiotics make management of gram-negative infections difficult, especially as resistance emerges against available agents.
• What they did: The review synthesizes how resistance arises via reduced drug entry, active efflux, antibiotic target modification, and enzymatic inactivation, highlighting clinically important resistant pathogens.
• The result: It emphasizes that effective management depends on timely, accurate diagnostics, targeted use of newer β-lactam agents, effective source control, and judicious treatment-duration selection.